Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             48 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Angiographic Morphology Following Heparin and Aspirin Therapy in Patients with Acute Coronary Syndromes and Intracoronary Thrombus Ran Kornowski
 1998
 5 2 p. 159-164
6 p.
 artikel
2 Angiographic Morphology Following Heparin and Aspirin Therapy in Patients with Acute Coronary Syndromes and Intracoronary Thrombus Kornowski, Ran
 1998
 5 2 p. 159-164
 artikel
3 Antiplatelet Therapy in Coronary Disease: What Agent to Use, When, and How? Pierre Theroux
 1998
 5 2 p. S143-S150
8 p.
 artikel
4 Antiplatelet Therapy in Coronary Disease: What Agent to Use, When, and How? Theroux, Pierre
 1998
 5 2 p. S143-S150
 artikel
5 Coronary Artery Disease: The View from Intravascular Ultrasound Steven E. Nissen
 1998
 5 2 p. S99-S111
13 p.
 artikel
6 Coronary Artery Disease: The View from Intravascular Ultrasound Nissen, Steven E.
 1998
 5 2 p. S99-S111
 artikel
7 Effect of a Change in the SleepWake Cycle on the Diurnal Variation of Fibrinolytic Parameters Masahiko Irokawa
 1998
 5 2 p. 165-168
4 p.
 artikel
8 Effect of a Change in the Sleep/Wake Cycle on the Diurnal Variation of Fibrinolytic Parameters Irokawa, Masahiko
 1998
 5 2 p. 165-168
 artikel
9 Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease Raymond L. Benza
 1998
 5 2 p. 143-150
8 p.
 artikel
10 Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease Benza, Raymond L.
 1998
 5 2 p. 143-150
 artikel
11 Health Economics of Acute Coronary Syndromes Daniel B. Mark
 1998
 5 2 p. S161-S168
8 p.
 artikel
12 Health Economics of Acute Coronary Syndromes Mark, Daniel B.
 1998
 5 2 p. S161-S168
 artikel
13 Human Plasma Fibronectin Mediates Adhesion of U937 Cells by RGD and CS1 Kazunobu Katoh
 1998
 5 2 p. 129-134
6 p.
 artikel
14 Human Plasma Fibronectin Mediates Adhesion of U937 Cells by RGD and CS1 Katoh, Kazunobu
 1998
 5 2 p. 129-134
 artikel
15 Identification of a BamHI Polymorphism for the Urokinase Gene Associated with Symptomatic Coronary Artery Disease Hernan E. Grenett
 1998
 5 2 p. 113-118
6 p.
 artikel
16 Identification of a BamHI Polymorphism for the Urokinase Gene Associated with Symptomatic Coronary Artery Disease Grenett, Hernan E.
 1998
 5 2 p. 113-118
 artikel
17 Impact of a Simple Inexpensive Quality Assurance Effort on Physicians Choice of Thrombolytic Agents and Door-to-Needle Time: Implication for Costs of Management Ursula A. Guidry
 1998
 5 2 p. 151-157
7 p.
 artikel
18 Impact of a Simple Inexpensive Quality Assurance Effort on Physician's Choice of Thrombolytic Agents and Door-to-Needle Time: Implication for Costs of Management Guidry, Ursula A.
 1998
 5 2 p. 151-157
 artikel
19 Interleukin-4 Modulation of Platelet-Derived Growth FactorInduced Smooth Muscle Cell Urokinase Plasminogen Activator Weizheng Wang
 1998
 5 2 p. 119-123
5 p.
 artikel
20 Interleukin-4 Modulation of Platelet-Derived Growth Factor–Induced Smooth Muscle Cell Urokinase Plasminogen Activator Wang, Weizheng
 1998
 5 2 p. 119-123
 artikel
21 Lack of Correlation Between Activation of Hemostatic Mechanism and Inflammation in Unstable Angina Pectoris Luigi Oltrona
 1998
 5 2 p. 169-173
5 p.
 artikel
22 Lack of Correlation Between Activation of Hemostatic Mechanism and Inflammation in Unstable Angina Pectoris Oltrona, Luigi
 1998
 5 2 p. 169-173
 artikel
23 New Agents, New Trials, New Solutions Robert M. Califf
 1998
 5 2 p. S151-S159
9 p.
 artikel
24 New Agents, New Trials, New Solutions Califf, Robert M.
 1998
 5 2 p. S151-S159
 artikel
25 New Thrombolytics: A Light at the End of the Tunnel? Frans Van de Werf
 1998
 5 2 p. S133-S135
3 p.
 artikel
26 New Thrombolytics: A Light at the End of the Tunnel? Van de Werf, Frans
 1998
 5 2 p. S133-S135
 artikel
27 Phosphorothioate Oligodeoxynucleotide Inhibition of Restenosis LeRoy E. Rabbani
 1998
 5 2 p. 125-128
4 p.
 artikel
28 Phosphorothioate Oligodeoxynucleotide Inhibition of Restenosis Rabbani, LeRoy E.
 1998
 5 2 p. 125-128
 artikel
29 Plaque Disruption: Pathogenesis and Prevention James S. Forrester
 1998
 5 2 p. S89-S97
9 p.
 artikel
30 Plaque Disruption: Pathogenesis and Prevention Forrester, James S.
 1998
 5 2 p. S89-S97
 artikel
31 Similarity in Presentation and Response to Thrombolysis Among Women and Men with Pulmonary Embolism Sanjay R. Patel
 1998
 5 2 p. 95-100
6 p.
 artikel
32 Similarity in Presentation and Response to Thrombolysis Among Women and Men with Pulmonary Embolism Patel, Sanjay R.
 1998
 5 2 p. 95-100
 artikel
33 St Segment Monitoring in Patients with Acute Ischemic Syndromes: Past and Future Anatoly Langer
 1998
 5 2 p. S119-S123
5 p.
 artikel
34 St Segment Monitoring in Patients with Acute Ischemic Syndromes: Past and Future Langer, Anatoly
 1998
 5 2 p. S119-S123
 artikel
35 The Antioxidant, N-(2-mercaptopropionyl)-glycine (MPG), Does Not Reduce Myocardial Infarct Size in an Acute Canine Model of Myocardial Ischemia and Reperfusion Catherine M. Venturini
 1998
 5 2 p. 135-141
7 p.
 artikel
36 The Antioxidant, N-(2-mercaptopropionyl)-glycine (MPG), Does Not Reduce Myocardial Infarct Size in an Acute Canine Model of Myocardial Ischemia and Reperfusion Venturini, Catherine M.
 1998
 5 2 p. 135-141
 artikel
37 The Open Artery Hypothesis: Past, Present, and Future Mukesh Goel
 1998
 5 2 p. 101-112
12 p.
 artikel
38 The Open Artery Hypothesis: Past, Present, and Future Goel, Mukesh
 1998
 5 2 p. 101-112
 artikel
39 The Role of Enzymatic Markers in the New Millennium: Point-of-Care Testing and Beyond L. Kristin Newby
 1998
 5 2 p. S113-S118
6 p.
 artikel
40 The Role of Enzymatic Markers in the New Millennium: Point-of-Care Testing and Beyond Newby, L. Kristin
 1998
 5 2 p. S113-S118
 artikel
41 The Thrombin Hypothesis: Dead or Alive? Elliott M. Antman
 1998
 5 2 p. S137-S141
5 p.
 artikel
42 The Thrombin Hypothesis: Dead or Alive? Antman, Elliott M.
 1998
 5 2 p. S137-S141
 artikel
43 Thrombolytic or Angioplasty Therapy of Evolving Myocardial Infarction? Eric J. Topol
 1998
 5 2 p. S125-S131
7 p.
 artikel
44 Thrombolytic or Angioplasty Therapy of Evolving Myocardial Infarction? Topol, Eric J.
 1998
 5 2 p. S125-S131
 artikel
45 Towards 2000New Strategies for Acute Coronary Syndromes (II) Paul Wayne Armstrong
 1998
 5 2 p. S85-S87
3 p.
 artikel
46 Towards 2000—New Strategies for Acute Coronary Syndromes (II) Armstrong, Paul Wayne
 1998
 5 2 p. S85-S87
 artikel
47 Use and Impact of Registries for Myocardial Infarction on Process of Care and Outcomes: Examples from Canada Jafna L. Cox
 1998
 5 2 p. S169-S175
7 p.
 artikel
48 Use and Impact of Registries for Myocardial Infarction on Process of Care and Outcomes: Examples from Canada Cox, Jafna L.
 1998
 5 2 p. S169-S175
 artikel
                             48 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland